Avantex Biotechnologies Inc, founded in Vancouver, is dedicated to improving patient quality of life through innovative drug treatments. With a commitment to bio-safety and efficacy, we focus on solving complex drug delivery challenges, including low bioavailability and systemic toxicity.
Collaborating with scientists and medical professionals, we've pioneered the Acufilic™ platform—an advanced nanotechnology that encapsulates dual drugs into nanoparticles. Our unique approach not only improves drug efficiency but also offers controlled release, reducing side effects and enhancing therapeutic outcomes for various health conditions.
As a local leader in the biotechnology industry, Avantex strives to deliver high-quality, cost-effective solutions to meet the evolving needs of healthcare providers and patients in Vancouver and beyond.
Collaborating with scientists and medical professionals, we've pioneered the Acufilic™ platform—an advanced nanotechnology that encapsulates dual drugs into nanoparticles. Our unique approach not only improves drug efficiency but also offers controlled release, reducing side effects and enhancing therapeutic outcomes for various health conditions.
As a local leader in the biotechnology industry, Avantex strives to deliver high-quality, cost-effective solutions to meet the evolving needs of healthcare providers and patients in Vancouver and beyond.
